Management Team
Jim Koziarz, PhD: President and Chief Executive Officer
- Has served in current role since 2008
- 25 years of experience in the Diagnostics Division at Abbott Laboratories; 12 years as a corporate officer
- Serves on multiple boards including Hycor Biomedical Inc., and Verax Biomedical, Inc.
- Chairman of Advisory Board for the College of Health and Sciences, DePaul University
- Earned PhD from the University of Chicago , BS from DePaul University
John Langmore, PhD: Co-Founder and Chief Scientific Officer
- Co-Founded company in 2000
- Former Professor in the Deparment of Biology at the University of Michigan serving as Chair of Biophysics Research
- Has extensive experience and over 40 publications
- Earned PhD from the University of Chicago
Betsy Long: Chief Finance Officer
- Joined Rubicon in December of 2009
- Active member and CFO of ARCH Development investment team
- Has played key role in guiding multiple ARCH portfolio companies through development
- Earned CPA and MA in accounting from Western Michigan University
Jim Babb, PhD: Chief Operating Officer
- COO role since 2011
- 20 years R&D Management at Abbott Diagnostics Division
- 10 years Independent Consulting of Start-ups and small businesses
- Earned PhD from Virginia Tech
Christine Haakenson, PhD: General Manager
- Joined Rubicon in 2012
- 16 years Executive and Management experience
- Earned PhD in Biochemistry from Georgetown; B.S. Chemical Engineering from Cornell
- General Manager since August 2012
Emmanuel Kamberov, PhD: VP of Research
- Earned Ph.D. from University of Plovdiv, Bulgaria
- Joined Rubicon in 2001
- Inventor on all company patents
- VP of Research since 2011
Takao Kurihara, Ph.D: Director of Manufacturing
- Joined Rubicon in May 2002
- Earned Ph.D. from Princeton University
- Co-inventor of Rubicon technologies
- Managed Commercial service activities since 2004
- Director of Manufacturing/Operations since 2009